We are pleased to announce the launch of generic Tolterodine 1mg and 2mg
film-coated tablets, and Tolterodine XL (Mariosea XL) 4mg capsules.
Tolterodine is a generic version of Detrusitol ^® (tolterodine) from Pfizer.
Tolterodine XL (Mariosea XL) is a generic version of Detrusitol ^® XL
(tolterodine XL) from Pfizer. Both are indicated in the symptomatic treatment
of urge incontinence and/or increased urinary frequency and urgency as may
occur in patients with overactive bladder syndrome. Please see the Summaries
of Product Characteristics for more in-depth information.
Tolterodine and Tolterodine XL (Mariosea XL) are available immediately in the
award-winning Teva 360 livery.
Kim Innes, Commercial Director at Teva said: "With the launch of tolterodine
in all strengths and formulations, we're making more medicines accessible for
more people. We've now launched twenty-four new products in 2012, and the
launch of tolterodine is our twelfth patent expiry of the year so far. It adds
to Teva's portfolio of medicines, which is already the UK's widest."
"More than 1.2 million prescriptions are written each year in the UK ^[ ^1 ^]
for tolterodine or tolterodine XL, and the availability of generic tolterodine
will save the NHS millions of pounds each year. It and other patent expiries
provide pharmacy the opportunities for increasing margins and keeping costs
down, and also mean we at Teva continue to do our bit in saving the NHS over
£9bn a year through the availability of generic medicines."
Loading...
Loading...
TEVATeva Pharmaceutical Industries Ltd
$16.30-1.39%
Edge Rankings
Momentum
23.50
Growth
24.28
Quality
25.78
Value
20.23
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.